$RGLS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Regulus Therapeutics Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Regulus Therapeutics Inc.. Get notifications about new insider transactions in Regulus Therapeutics Inc. for free.

Page:   < prev 1 2 3 4 5 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 02 2017RGLSRegulus Therapeuti ...FOLETTA MARK GDirectorOption ExerciseA1.4530,00043,50030,000
Jun 02 2017RGLSRegulus Therapeuti ...BALTIMORE DAVIDDirectorOption ExerciseA1.4530,00043,50030,000
Jun 02 2017RGLSRegulus Therapeuti ...Witz PascaleDirectorOption ExerciseA1.4560,00087,00060,000
May 12 2017RGLSRegulus Therapeuti ...Chevallard Daniel R.Chief Financial Off ...Option ExerciseA1.65100,000165,000100,000
May 08 2017RGLSRegulus Therapeuti ...Hagan Joseph PPresident and CEOOption ExerciseA1.70750,0001,275,000750,000
May 08 2017RGLSRegulus Therapeuti ...WRIGHT TIMOTHY MICHAELChief R & D OfficerOption ExerciseA1.70350,000595,000350,000
Mar 23 2017RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorBuyP1.23300,000368,100700,677400.7 K to 700.7 K (+74.87 %)
Mar 23 2017RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorBuyP1.20200,000239,800400,677200.7 K to 400.7 K (+99.66 %)
Mar 07 2017RGLSRegulus Therapeuti ...RASTETTER WILLIAM HDirectorBuyP1.15250,000287,500350,000100 K to 350 K (+250.00 %)
Feb 23 2017RGLSRegulus Therapeuti ...WRIGHT TIMOTHY MICHAELChief R & D OfficerOption ExerciseA1.2032,41238,89432,412
Feb 23 2017RGLSRegulus Therapeuti ...Hagan Joseph PChief Operating Off ...Option ExerciseA1.20160,000192,000160,000
Feb 23 2017RGLSRegulus Therapeuti ...GRINT PAUL CPresident & CEOOption ExerciseA1.20410,000492,000410,000
Feb 01 2017RGLSRegulus Therapeuti ...Hagan Joseph PChief Operating Off ...Option ExerciseA5.7730,000173,10030,000
Feb 01 2017RGLSRegulus Therapeuti ...GRINT PAUL CPresident & CEOOption ExerciseA6.35130,000825,500130,000
Oct 07 2016RGLSRegulus Therapeuti ...Hagan Joseph PChief Operating Off ...Option ExerciseA3.5259,625209,88059,625
Oct 07 2016RGLSRegulus Therapeuti ...GRINT PAUL CPresident & CEOOption ExerciseA3.52186,640656,973186,640
Oct 05 2016RGLSRegulus Therapeuti ...WRIGHT TIMOTHY MICHAELChief R & D OfficerOption ExerciseA3.30450,0001,485,000450,000
Jun 03 2016RGLSRegulus Therapeuti ...WILLIAMS DOUGLAS EDirectorOption ExerciseA6.2036,620227,04436,620
Jun 03 2016RGLSRegulus Therapeuti ...RASTETTER WILLIAM HDirectorOption ExerciseA6.2036,620227,04436,620
Jun 03 2016RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorOption ExerciseA6.2036,620227,04436,620
Jun 03 2016RGLSRegulus Therapeuti ...FOLETTA MARK GDirectorOption ExerciseA6.2036,620227,04436,620
Jun 03 2016RGLSRegulus Therapeuti ...BALTIMORE DAVIDDirectorOption ExerciseA6.2036,620227,04436,620
Jun 03 2016RGLSRegulus Therapeuti ...Rosen HughDirectorOption ExerciseA6.2070,952439,90270,952
Mar 07 2016RGLSRegulus Therapeuti ...Hagan Joseph PChief Operating Off ...BuyP7.1910,00071,90010,0000 to 10 K
Feb 24 2016RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS7.181,000,0007,180,0004,896,7165.9 M to 4.9 M (-16.96 %)
Feb 05 2016RGLSRegulus Therapeuti ...GRINT PAUL CPresident & CEOOption ExerciseA6.35265,0001,682,750265,000
Jan 06 2016RGLSRegulus Therapeuti ...GRINT PAUL CPresident & CEOOption ExerciseA7.5830,000227,40030,000
Jan 06 2016RGLSRegulus Therapeuti ...Hagan Joseph PChief Operating Off ...Option ExerciseA8.57420,0003,599,400420,000
Aug 13 2015RGLSRegulus Therapeuti ...FOLETTA MARK GDirectorBuyP7.6410,00076,40510,0000 to 10 K
Aug 07 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorOption ExerciseM2.6615,67741,7011,823
Aug 07 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorOption ExerciseM1.7417,50030,4500
Aug 07 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorOption ExerciseM0.3817,5006,6500
Aug 07 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorBuyM2.6615,67741,701200,677185 K to 200.7 K (+8.47 %)
Aug 07 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorBuyM1.7417,50030,450185,000167.5 K to 185 K (+10.45 %)
Aug 07 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorBuyM0.3817,5006,650167,500150 K to 167.5 K (+11.67 %)
Jul 21 2015RGLSRegulus Therapeuti ...RASTETTER WILLIAM HDirectorBuyP10.1961,235624,199100,00038.8 K to 100 K (+157.96 %)
Jul 21 2015RGLSRegulus Therapeuti ...RASTETTER WILLIAM HDirectorBuyP10.1338,765392,77938,7650 to 38.8 K
Jul 17 2015RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INC10% OwnerSellS10.21111,0001,133,7545,173,1725.3 M to 5.2 M (-2.10 %)
Jul 17 2015RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INC10% OwnerSellS10.79167,0001,801,3625,284,1725.5 M to 5.3 M (-3.06 %)
Jul 17 2015RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INC10% OwnerSellS10.7665,133700,9615,451,1725.5 M to 5.5 M (-1.18 %)
Jul 02 2015RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INC10% OwnerSellS10.7913,248143,0105,516,3055.5 M to 5.5 M (-0.24 %)
Jul 02 2015RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INC10% OwnerGiftG0.0013,24805,529,5535.5 M to 5.5 M (+0.24 %)
Jun 26 2015RGLSRegulus Therapeuti ...GRINT PAUL CPresident & CEOOption ExerciseA10.22500,0005,110,000500,000
Jun 26 2015RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorOption ExerciseA10.0217,500175,35017,500
Jun 26 2015RGLSRegulus Therapeuti ...FOLETTA MARK GDirectorOption ExerciseA10.0217,500175,35017,500
Jun 26 2015RGLSRegulus Therapeuti ...RASTETTER WILLIAM HDirectorOption ExerciseA10.0217,500175,35017,500
Jun 26 2015RGLSRegulus Therapeuti ...CARTER BRUCE L ADirectorOption ExerciseA10.0217,500175,35017,500
Jun 26 2015RGLSRegulus Therapeuti ...BALTIMORE DAVIDDirectorOption ExerciseA10.0217,500175,35017,500
Jun 26 2015RGLSRegulus Therapeuti ...CARTER BRUCE L ADirectorOption ExerciseA10.0217,500175,35017,500
Jun 26 2015RGLSRegulus Therapeuti ...WILLIAMS DOUGLAS EDirectorOption ExerciseA10.0217,500175,35017,500
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3860,00022,8008,287
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3866,07125,10768,287
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3873,92928,093134,358
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS17.7360,0001,063,9803,70563.7 K to 3.7 K (-94.18 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3860,00022,80063,7053.7 K to 63.7 K (+1,619.43 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS16.8566,0711,113,5143,70569.8 K to 3.7 K (-94.69 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3866,07125,10769,7763.7 K to 69.8 K (+1,783.29 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS16.9473,9291,252,0023,70577.6 K to 3.7 K (-95.23 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3873,92928,09377,6343.7 K to 77.6 K (+1,995.38 %)
Apr 14 2015RGLSRegulus Therapeuti ...CARTER BRUCE L ADirectorOption ExerciseM4.7820,00095,60010,000
Apr 14 2015RGLSRegulus Therapeuti ...CARTER BRUCE L ADirectorSellS17.6620,000353,164020 K to 0 (-100.00 %)
Apr 14 2015RGLSRegulus Therapeuti ...CARTER BRUCE L ADirectorBuyM4.7820,00095,60020,0000 to 20 K
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3889,23033,907208,287
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS20.8123,616491,5512,46626.1 K to 2.5 K (-90.55 %)
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS20.0665,6141,316,51226,08291.7 K to 26.1 K (-71.56 %)
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3889,23033,90791,6962.5 K to 91.7 K (+3,618.41 %)
Mar 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.387027297,517
Mar 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS19.50701,3652,4662.5 K to 2.5 K (-2.76 %)
Mar 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3870272,5362.5 K to 2.5 K (+2.84 %)
Feb 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.382,400912297,587
Feb 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.383,3001,254299,987
Feb 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS19.772,40047,4402,4664.9 K to 2.5 K (-49.32 %)
Feb 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.382,4009124,8662.5 K to 4.9 K (+97.32 %)
Feb 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS19.503,30064,3512,4665.8 K to 2.5 K (-57.23 %)
Feb 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.383,3001,2545,7662.5 K to 5.8 K (+133.82 %)
Jan 30 2015RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS18.668,655161,49308.7 K to 0 (-100.00 %)
Jan 30 2015RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS17.9871,3451,282,8128,65580 K to 8.7 K (-89.18 %)
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3860,00022,800303,287
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3885,00032,300363,287
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS18.4026,227482,6272,46628.7 K to 2.5 K (-91.41 %)
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS17.7733,773600,00828,69362.5 K to 28.7 K (-54.07 %)
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3860,00022,80062,4662.5 K to 62.5 K (+2,433.09 %)
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS18.6912,989242,7012,46615.5 K to 2.5 K (-84.04 %)
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS17.9772,0111,293,81415,45587.5 K to 15.5 K (-82.33 %)
Jan 30 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3885,00032,30087,4662.5 K to 87.5 K (+3,446.88 %)
Dec 15 2014RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorOption ExerciseM0.38150,00057,0000
Dec 15 2014RGLSRegulus Therapeuti ...PAPADOPOULOS STELIOSDirectorBuyM0.38150,00057,000150,0000 to 150 K
Dec 04 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseA17.76231,6344,113,820231,634
Dec 04 2014RGLSRegulus Therapeuti ...Szekeres David LeslieChief Business Offi ...Option ExerciseA17.7681,1011,440,35481,101
Dec 04 2014RGLSRegulus Therapeuti ...GRINT PAUL CChief Medical Offic ...Option ExerciseA17.7650,870903,45150,870
Dec 04 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...Option ExerciseA17.7690,3781,605,11390,378
Dec 01 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...Option ExerciseM1.742,5004,350111,500
Dec 01 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS19.631,50029,44580,00081.5 K to 80 K (-1.84 %)
Dec 01 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS18.801,00018,80081,50082.5 K to 81.5 K (-1.21 %)
Dec 01 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...BuyM1.742,5004,35082,50080 K to 82.5 K (+3.13 %)
Nov 14 2014RGLSRegulus Therapeuti ...ASTRAZENECA PLC10% OwnerSellS17.002,000,00034,000,0004,250,0006.3 M to 4.3 M (-32.00 %)
Nov 05 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INC10% OwnerSellS15.941,279,41120,390,6135,516,3056.8 M to 5.5 M (-18.83 %)
Oct 31 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.383,5051,332448,287
Oct 31 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS20.411002,0412,4662.6 K to 2.5 K (-3.90 %)
Oct 31 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS19.782,00539,6592,5664.6 K to 2.6 K (-43.86 %)
Oct 31 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS18.661,40026,1244,5716 K to 4.6 K (-23.45 %)
Oct 31 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.383,5051,3325,9712.5 K to 6 K (+142.13 %)
Oct 31 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...Option ExerciseM1.742,5004,350114,000
Oct 31 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS20.412004,08280,00080.2 K to 80 K (-0.25 %)
Oct 31 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS19.671,20023,60480,20081.4 K to 80.2 K (-1.47 %)
Oct 31 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS18.681,10020,54881,40082.5 K to 81.4 K (-1.33 %)
Oct 31 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...BuyM1.742,5004,35082,50080 K to 82.5 K (+3.13 %)
Oct 24 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS15.191,85028,1096,795,7166.8 M to 6.8 M (-0.03 %)
Oct 24 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS14.241,70024,2026,797,5666.8 M to 6.8 M (-0.03 %)
Oct 24 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS14.00109,5341,533,1256,799,2666.9 M to 6.8 M (-1.59 %)
Oct 24 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS15.191,85028,1095,896,7165.9 M to 5.9 M (-0.03 %)
Oct 24 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS14.241,70024,2025,898,5665.9 M to 5.9 M (-0.03 %)
Oct 24 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS14.00109,5341,533,1255,900,2666 M to 5.9 M (-1.82 %)
Oct 22 2014RGLSRegulus Therapeuti ...Szekeres David LeslieCBO and General Cou ...Option ExerciseA8.5140,000340,40040,000
Oct 22 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...Option ExerciseA6.1340,000245,20040,000
Oct 24 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...Option ExerciseM1.743,3005,742116,500
Oct 24 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...SellS14.443,30047,64480,00083.3 K to 80 K (-3.96 %)
Oct 24 2014RGLSRegulus Therapeuti ...Gibson Neil WChief Scientific Of ...BuyM1.743,3005,74283,30080 K to 83.3 K (+4.13 %)
Oct 22 2014RGLSRegulus Therapeuti ...GRINT PAUL CChief Medical Offic ...Option ExerciseA7.5840,000303,20040,000
Oct 22 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseA6.1388,000539,44088,000
Oct 21 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.38300114451,792
Oct 21 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.38400152452,092
Oct 21 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS7.003002,1002,4662.8 K to 2.5 K (-10.85 %)
Oct 21 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.383001142,7662.5 K to 2.8 K (+12.17 %)
Oct 21 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS7.044002,8162,4662.9 K to 2.5 K (-13.96 %)
Oct 21 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.384001522,8662.5 K to 2.9 K (+16.22 %)
Oct 17 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.793,00020,3716,908,8006.9 M to 6.9 M (-0.04 %)
Oct 17 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.764,80032,4506,911,8006.9 M to 6.9 M (-0.07 %)
Oct 17 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.674,30028,6876,916,6006.9 M to 6.9 M (-0.06 %)
Oct 17 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.793,00020,3716,009,8006 M to 6 M (-0.05 %)
Oct 17 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.764,80032,4506,012,8006 M to 6 M (-0.08 %)
Oct 17 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.674,30028,6876,017,6006 M to 6 M (-0.07 %)
Oct 14 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.38400152452,492
Oct 14 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3810540452,892
Oct 14 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS7.004002,8002,4662.9 K to 2.5 K (-13.96 %)
Oct 14 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.384001522,8662.5 K to 2.9 K (+16.22 %)
Oct 14 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS7.001057352,4662.6 K to 2.5 K (-4.08 %)
Oct 14 2014RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.38105402,5712.5 K to 2.6 K (+4.26 %)
Oct 10 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.412,00012,8136,920,9006.9 M to 6.9 M (-0.03 %)
Oct 10 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.584,75031,2386,922,9006.9 M to 6.9 M (-0.07 %)
Oct 10 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.633,30021,8886,927,6506.9 M to 6.9 M (-0.05 %)
Oct 10 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.412,00012,8136,021,9006 M to 6 M (-0.03 %)
Oct 10 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.584,75031,2386,023,9006 M to 6 M (-0.08 %)
Oct 10 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.633,30021,8886,028,6506 M to 6 M (-0.05 %)
Oct 03 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.883,30022,6886,930,9506.9 M to 6.9 M (-0.05 %)
Oct 03 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.643,75024,9036,934,2506.9 M to 6.9 M (-0.05 %)
Oct 03 2014RGLSRegulus Therapeuti ...ISIS PHARMACEUTICALS INCDirectorSellS6.713,25021,8086,938,0006.9 M to 6.9 M (-0.05 %)
Oct 03 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.883,30022,6886,031,9506 M to 6 M (-0.05 %)
Oct 03 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.643,75024,9036,035,2506 M to 6 M (-0.06 %)
Oct 03 2014RGLSRegulus Therapeuti ...ALNYLAM PHARMACEUTICALS, INC.10% OwnerSellS6.713,25021,8086,039,0006 M to 6 M (-0.05 %)

Page:   < prev 1 2 3 4 5 next >